Psychedelic drugs aren’t just some “here today, gone tomorrow” phenomenon.
Not by a long shot.
Instead, such treatments – like psilocybin mushrooms — are only just beginning to boom.
It’s part of the reason that Eight Capital estimates the total market for mental health treatment could be valued at up to $100 billion.
Just days ago, the Canadian government allowed four terminally ill patients with cancer to receive psilocybin therapy to help ease end-of-life distress. This is the first time in 46 years that an exemption has been given in Canada for patients to access such treatment.
There’s plenty of support for it in the U.S., too.
For example Denver, Oakland, and Santa Cruz have recently legalized its use. Washington, D.C. and Oregon residents will vote on its legalization in the upcoming November 2020 elections.
The best part — such drugs are already proving to be a major game changer for millions of people all over the world. Countless studies are already proving such treatments can treat a host of mental issues, like obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, depression, anxiety, and eating disorders.